

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 5.95482984 |
| 2 | lysine catabolic process (GO:0006554) | 5.95482984 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 5.21374922 |
| 4 | 2-oxoglutarate metabolic process (GO:0006103) | 4.79127153 |
| 5 | aspartate family amino acid catabolic process (GO:0009068) | 4.68386570 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.55552783 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.55552783 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.55317465 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.55317465 |
| 10 | cysteine metabolic process (GO:0006534) | 4.44639361 |
| 11 | ribosome assembly (GO:0042255) | 4.40818130 |
| 12 | NADH metabolic process (GO:0006734) | 4.38657465 |
| 13 | carnitine shuttle (GO:0006853) | 4.38470050 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.30317460 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 4.27866842 |
| 16 | oxaloacetate metabolic process (GO:0006107) | 4.21385240 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 4.21153402 |
| 18 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.18532755 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.08200775 |
| 20 | homocysteine metabolic process (GO:0050667) | 3.98824715 |
| 21 | muscle filament sliding (GO:0030049) | 3.95537646 |
| 22 | actin-myosin filament sliding (GO:0033275) | 3.95537646 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 3.92947400 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 3.92831109 |
| 25 | tricarboxylic acid metabolic process (GO:0072350) | 3.91265203 |
| 26 | acetyl-CoA metabolic process (GO:0006084) | 3.87620275 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 3.85601978 |
| 28 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84220305 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 3.83969937 |
| 30 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.82624811 |
| 31 | nuclear pore organization (GO:0006999) | 3.74677025 |
| 32 | succinate metabolic process (GO:0006105) | 3.73605742 |
| 33 | fatty acid beta-oxidation (GO:0006635) | 3.72779709 |
| 34 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.72459216 |
| 35 | fatty acid homeostasis (GO:0055089) | 3.71664753 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.70794815 |
| 37 | regulation of cofactor metabolic process (GO:0051193) | 3.70733120 |
| 38 | regulation of coenzyme metabolic process (GO:0051196) | 3.70733120 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.69330282 |
| 40 | glycine metabolic process (GO:0006544) | 3.67180534 |
| 41 | nuclear pore complex assembly (GO:0051292) | 3.65502411 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 3.60673479 |
| 43 | establishment of integrated proviral latency (GO:0075713) | 3.60638433 |
| 44 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.59434784 |
| 45 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.56087730 |
| 46 | branched-chain amino acid catabolic process (GO:0009083) | 3.55360413 |
| 47 | DNA unwinding involved in DNA replication (GO:0006268) | 3.53320515 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 3.53165242 |
| 49 | glutamate metabolic process (GO:0006536) | 3.51958871 |
| 50 | mitotic sister chromatid cohesion (GO:0007064) | 3.51217159 |
| 51 | serine family amino acid metabolic process (GO:0009069) | 3.50628902 |
| 52 | fatty acid oxidation (GO:0019395) | 3.49071303 |
| 53 | valine metabolic process (GO:0006573) | 3.48570860 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 3.47152257 |
| 55 | actin-mediated cell contraction (GO:0070252) | 3.46883204 |
| 56 | COPI coating of Golgi vesicle (GO:0048205) | 3.45944867 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 3.45944867 |
| 58 | regulation of translational fidelity (GO:0006450) | 3.44904683 |
| 59 | regulation of fatty acid oxidation (GO:0046320) | 3.43551755 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 3.42752443 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 3.42752443 |
| 62 | tryptophan catabolic process (GO:0006569) | 3.42752443 |
| 63 | lipid oxidation (GO:0034440) | 3.40111677 |
| 64 | IMP metabolic process (GO:0046040) | 3.39634034 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.39524368 |
| 66 | urea cycle (GO:0000050) | 3.38555633 |
| 67 | urea metabolic process (GO:0019627) | 3.38555633 |
| 68 | amino-acid betaine transport (GO:0015838) | 3.37893686 |
| 69 | carnitine transport (GO:0015879) | 3.37893686 |
| 70 | tryptophan metabolic process (GO:0006568) | 3.34844324 |
| 71 | branched-chain amino acid metabolic process (GO:0009081) | 3.33046017 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 3.32592351 |
| 73 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.31619777 |
| 74 | positive regulation of fatty acid oxidation (GO:0046321) | 3.31547548 |
| 75 | carnitine transmembrane transport (GO:1902603) | 3.31430248 |
| 76 | carnitine metabolic process (GO:0009437) | 3.30953023 |
| 77 | fatty acid catabolic process (GO:0009062) | 3.30458102 |
| 78 | ketone body metabolic process (GO:1902224) | 3.29852895 |
| 79 | biotin metabolic process (GO:0006768) | 3.29775548 |
| 80 | protein complex localization (GO:0031503) | 3.22268801 |
| 81 | bile acid biosynthetic process (GO:0006699) | 3.22122807 |
| 82 | formation of translation preinitiation complex (GO:0001731) | 3.21764617 |
| 83 | COPII vesicle coating (GO:0048208) | 3.20163340 |
| 84 | mitotic metaphase plate congression (GO:0007080) | 3.18577174 |
| 85 | regulation of sulfur metabolic process (GO:0042762) | 3.17134399 |
| 86 | cellular protein complex localization (GO:0034629) | 3.15625734 |
| 87 | protein localization to chromosome, centromeric region (GO:0071459) | 3.14276746 |
| 88 | IMP biosynthetic process (GO:0006188) | 3.13950286 |
| 89 | 4-hydroxyproline metabolic process (GO:0019471) | 3.12929659 |
| 90 | monocarboxylic acid catabolic process (GO:0072329) | 3.12276860 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.09585483 |
| 92 | organic acid catabolic process (GO:0016054) | 3.09585483 |
| 93 | mitotic chromosome condensation (GO:0007076) | 3.08295642 |
| 94 | nitrogen cycle metabolic process (GO:0071941) | 3.05682531 |
| 95 | dicarboxylic acid catabolic process (GO:0043649) | 3.03482427 |
| 96 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.03329844 |
| 97 | negative regulation of fibrinolysis (GO:0051918) | 2.98009248 |
| 98 | dicarboxylic acid metabolic process (GO:0043648) | 2.97909338 |
| 99 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.97739715 |
| 100 | gluconeogenesis (GO:0006094) | 2.97291042 |
| 101 | serine family amino acid biosynthetic process (GO:0009070) | 2.97193878 |
| 102 | aromatic amino acid family metabolic process (GO:0009072) | 2.97180239 |
| 103 | regulation of protein activation cascade (GO:2000257) | 2.97169080 |
| 104 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.95456523 |
| 105 | protein localization to kinetochore (GO:0034501) | 2.94900814 |
| 106 | acylglycerol homeostasis (GO:0055090) | 2.94535986 |
| 107 | triglyceride homeostasis (GO:0070328) | 2.94535986 |
| 108 | drug catabolic process (GO:0042737) | 2.94317591 |
| 109 | metaphase plate congression (GO:0051310) | 2.93421862 |
| 110 | complement activation, alternative pathway (GO:0006957) | 2.88730895 |
| 111 | urate metabolic process (GO:0046415) | 2.87027004 |
| 112 | ethanol oxidation (GO:0006069) | 2.86071678 |
| 113 | epoxygenase P450 pathway (GO:0019373) | 2.85275050 |
| 114 | high-density lipoprotein particle remodeling (GO:0034375) | 2.85217263 |
| 115 | coenzyme catabolic process (GO:0009109) | 2.84242604 |
| 116 | bile acid metabolic process (GO:0008206) | 2.81323461 |
| 117 | regulation of complement activation (GO:0030449) | 2.80815461 |
| 118 | regulation of translational elongation (GO:0006448) | 2.80615350 |
| 119 | regulation of triglyceride catabolic process (GO:0010896) | 2.80316110 |
| 120 | regulation of sequestering of triglyceride (GO:0010889) | 2.80064770 |
| 121 | quaternary ammonium group transport (GO:0015697) | 2.79789549 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 2.78682308 |
| 123 | hexose biosynthetic process (GO:0019319) | 2.77564756 |
| 124 | drug transmembrane transport (GO:0006855) | 2.77563473 |
| 125 | tyrosine metabolic process (GO:0006570) | 2.76343083 |
| 126 | regulation of centriole replication (GO:0046599) | 2.76208370 |
| 127 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.75735873 |
| 128 | tRNA aminoacylation for protein translation (GO:0006418) | 2.74346312 |
| 129 | non-recombinational repair (GO:0000726) | 2.73819689 |
| 130 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.73819689 |
| 131 | regulation of sister chromatid cohesion (GO:0007063) | 2.71310260 |
| 132 | CENP-A containing nucleosome assembly (GO:0034080) | 2.71075684 |
| 133 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.68627093 |
| 134 | amino acid activation (GO:0043038) | 2.67551291 |
| 135 | tRNA aminoacylation (GO:0043039) | 2.67551291 |
| 136 | establishment of viral latency (GO:0019043) | 2.64463142 |
| 137 | oxidative phosphorylation (GO:0006119) | 2.63905586 |
| 138 | sarcomere organization (GO:0045214) | 2.63324355 |
| 139 | paraxial mesoderm development (GO:0048339) | 2.61799053 |
| 140 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.60970838 |
| 141 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.60832274 |
| 142 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.60832274 |
| 143 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.60701146 |
| 144 | glycolytic process (GO:0006096) | 2.59377862 |
| 145 | skeletal muscle contraction (GO:0003009) | 2.58231790 |
| 146 | positive regulation of chromosome segregation (GO:0051984) | 2.58063107 |
| 147 | establishment of chromosome localization (GO:0051303) | 2.56159290 |
| 148 | protein maturation by protein folding (GO:0022417) | 2.53536377 |
| 149 | actin filament-based movement (GO:0030048) | 2.50488185 |
| 150 | chromatin remodeling at centromere (GO:0031055) | 2.50204871 |
| 151 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.46415664 |
| 152 | purine nucleobase biosynthetic process (GO:0009113) | 2.42596862 |
| 153 | pore complex assembly (GO:0046931) | 2.41955448 |
| 154 | mitochondrial fusion (GO:0008053) | 2.41231712 |
| 155 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.39221516 |
| 156 | glucan biosynthetic process (GO:0009250) | 2.38476429 |
| 157 | glycogen biosynthetic process (GO:0005978) | 2.38476429 |
| 158 | ribonucleoprotein complex disassembly (GO:0032988) | 2.36935382 |
| 159 | proteasome assembly (GO:0043248) | 2.36417405 |
| 160 | mitochondrial DNA metabolic process (GO:0032042) | 2.36175644 |
| 161 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.35754880 |
| 162 | ribosome biogenesis (GO:0042254) | 2.34962182 |
| 163 | mitotic nuclear envelope disassembly (GO:0007077) | 2.34938972 |
| 164 | sister chromatid segregation (GO:0000819) | 2.34872698 |
| 165 | mitotic nuclear envelope reassembly (GO:0007084) | 2.34487355 |
| 166 | nuclear envelope reassembly (GO:0031468) | 2.34487355 |
| 167 | glutamine metabolic process (GO:0006541) | 2.33780348 |
| 168 | regulation of mitochondrial translation (GO:0070129) | 2.32308929 |
| 169 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.31466866 |
| 170 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.31466866 |
| 171 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.31466866 |
| 172 | mitotic sister chromatid segregation (GO:0000070) | 2.30419189 |
| 173 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.28509529 |
| 174 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.28159810 |
| 175 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.27918364 |
| 176 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.26254154 |
| 177 | ventricular cardiac muscle cell development (GO:0055015) | 2.26069786 |
| 178 | DNA topological change (GO:0006265) | 2.25717167 |
| 179 | DNA strand elongation (GO:0022616) | 2.25378294 |
| 180 | protein localization to microtubule (GO:0035372) | 2.24237935 |
| 181 | histone exchange (GO:0043486) | 2.22177620 |
| 182 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.21896315 |
| 183 | striated muscle contraction (GO:0006941) | 2.20373720 |
| 184 | membrane disassembly (GO:0030397) | 2.19037873 |
| 185 | nuclear envelope disassembly (GO:0051081) | 2.19037873 |
| 186 | peptidyl-arginine N-methylation (GO:0035246) | 2.18716776 |
| 187 | peptidyl-arginine methylation (GO:0018216) | 2.18716776 |
| 188 | DNA ligation (GO:0006266) | 2.18364528 |
| 189 | notochord development (GO:0030903) | 2.18212210 |
| 190 | DNA replication-independent nucleosome organization (GO:0034724) | 2.18158573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.08079530 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.16163883 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.00179221 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.47222560 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.84071748 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.41299310 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.98415553 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.94394214 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.93721767 |
| 10 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.92718203 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.67998203 |
| 12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.67794478 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.52620432 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.48677958 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.42987667 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.39852927 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.31617060 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27885366 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.26086113 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.24042674 |
| 21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.20987710 |
| 22 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.17276842 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10471857 |
| 24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.09859728 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.08912270 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06054968 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.04391215 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.03373859 |
| 29 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.03191772 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.02027884 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.01968149 |
| 32 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.99612141 |
| 33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.99359442 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.98029300 |
| 35 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.91203265 |
| 36 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.83419973 |
| 37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.82118629 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.80820234 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75653249 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73763541 |
| 41 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71884773 |
| 42 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.70434167 |
| 43 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.70241419 |
| 44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.68214821 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67530285 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67439568 |
| 47 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.59973128 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59355511 |
| 49 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.56925960 |
| 50 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.56908333 |
| 51 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55075823 |
| 52 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.52168720 |
| 53 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.50842663 |
| 54 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48733821 |
| 55 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.47828861 |
| 56 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46895524 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.46543143 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44812264 |
| 59 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.38767310 |
| 60 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.36734162 |
| 61 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34634300 |
| 62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33799468 |
| 63 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.33323720 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29564618 |
| 65 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.29233649 |
| 66 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.28646004 |
| 67 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.28248911 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.25572552 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25544641 |
| 70 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.25250656 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23965821 |
| 72 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23685076 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23266184 |
| 74 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.21765960 |
| 75 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.20268384 |
| 76 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.20123800 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19740935 |
| 78 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18522969 |
| 79 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17476082 |
| 80 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17166305 |
| 81 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16960708 |
| 82 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16450671 |
| 83 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16140452 |
| 84 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.15904400 |
| 85 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.15377763 |
| 86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15183581 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15139373 |
| 88 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.15082472 |
| 89 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14982058 |
| 90 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13957437 |
| 91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13025709 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11881706 |
| 93 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11765647 |
| 94 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.09921206 |
| 95 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07864938 |
| 96 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07862245 |
| 97 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07384128 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06655615 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06655615 |
| 100 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05100045 |
| 101 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04272382 |
| 102 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03633894 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03194566 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01418632 |
| 105 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01177259 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00677282 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99525633 |
| 108 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98238850 |
| 109 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.97449399 |
| 110 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.97237949 |
| 111 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97012985 |
| 112 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.96892219 |
| 113 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96872207 |
| 114 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96391991 |
| 115 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.96040468 |
| 116 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.95575690 |
| 117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95449155 |
| 118 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94890718 |
| 119 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94422887 |
| 120 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94116793 |
| 121 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94027508 |
| 122 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93109090 |
| 123 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93097935 |
| 124 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92437678 |
| 125 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91724624 |
| 126 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.91215642 |
| 127 | EWS_26573619_Chip-Seq_HEK293_Human | 0.90276442 |
| 128 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.89066861 |
| 129 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88615089 |
| 130 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88603432 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88582078 |
| 132 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87008533 |
| 133 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.86781075 |
| 134 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.85451653 |
| 135 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.83861163 |
| 136 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.83737888 |
| 137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83192109 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82697947 |
| 139 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.82651362 |
| 140 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.81914256 |
| 141 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81869017 |
| 142 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81512105 |
| 143 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80642835 |
| 144 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80457164 |
| 145 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.79913032 |
| 146 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.79843595 |
| 147 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.79700277 |
| 148 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.79540363 |
| 149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78598663 |
| 150 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.78481595 |
| 151 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.78172407 |
| 152 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77274034 |
| 153 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.76814574 |
| 154 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74957225 |
| 155 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.74694204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.22643889 |
| 2 | MP0005360_urolithiasis | 4.39559102 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.37809606 |
| 4 | MP0005365_abnormal_bile_salt | 4.30284168 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.27551635 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.88859182 |
| 7 | MP0003252_abnormal_bile_duct | 2.70810144 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.69667608 |
| 9 | MP0003646_muscle_fatigue | 2.62790877 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.53946296 |
| 11 | MP0003941_abnormal_skin_development | 2.39284397 |
| 12 | MP0003111_abnormal_nucleus_morphology | 2.37201500 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.34850588 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.29271939 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.21791057 |
| 16 | MP0005332_abnormal_amino_acid | 2.19163350 |
| 17 | MP0008057_abnormal_DNA_replication | 2.18655929 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.18339068 |
| 19 | MP0004130_abnormal_muscle_cell | 2.08614354 |
| 20 | MP0003195_calcinosis | 2.04046732 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.03248290 |
| 22 | MP0003077_abnormal_cell_cycle | 1.95959439 |
| 23 | MP0004215_abnormal_myocardial_fiber | 1.91989656 |
| 24 | MP0005083_abnormal_biliary_tract | 1.90486081 |
| 25 | MP0003123_paternal_imprinting | 1.78234883 |
| 26 | MP0008932_abnormal_embryonic_tissue | 1.74739311 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.72868631 |
| 28 | MP0005330_cardiomyopathy | 1.69392018 |
| 29 | MP0004036_abnormal_muscle_relaxation | 1.68624520 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.66653045 |
| 31 | MP0000751_myopathy | 1.64541827 |
| 32 | MP0004043_abnormal_pH_regulation | 1.62945729 |
| 33 | MP0002269_muscular_atrophy | 1.60628498 |
| 34 | MP0003221_abnormal_cardiomyocyte_apopto | 1.59704644 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.59335207 |
| 36 | MP0009840_abnormal_foam_cell | 1.57675233 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.56220878 |
| 38 | MP0004233_abnormal_muscle_weight | 1.50731859 |
| 39 | MP0009697_abnormal_copulation | 1.50606495 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.49339757 |
| 41 | MP0002009_preneoplasia | 1.47387504 |
| 42 | MP0004270_analgesia | 1.42326274 |
| 43 | MP0004087_abnormal_muscle_fiber | 1.40861305 |
| 44 | MP0002118_abnormal_lipid_homeostasis | 1.38953917 |
| 45 | MP0008058_abnormal_DNA_repair | 1.38600492 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.37302624 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.36590254 |
| 48 | MP0000609_abnormal_liver_physiology | 1.35473531 |
| 49 | MP0000350_abnormal_cell_proliferation | 1.30690772 |
| 50 | MP0001661_extended_life_span | 1.25337292 |
| 51 | MP0003283_abnormal_digestive_organ | 1.25074063 |
| 52 | MP0000733_abnormal_muscle_development | 1.25029971 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 1.21984951 |
| 54 | MP0002080_prenatal_lethality | 1.21129101 |
| 55 | MP0004272_abnormal_basement_membrane | 1.21074743 |
| 56 | MP0001299_abnormal_eye_distance/ | 1.19877909 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.18408275 |
| 58 | MP0003868_abnormal_feces_composition | 1.18014373 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.17841265 |
| 60 | MP0006138_congestive_heart_failure | 1.17706862 |
| 61 | MP0010630_abnormal_cardiac_muscle | 1.17653005 |
| 62 | MP0002972_abnormal_cardiac_muscle | 1.16866279 |
| 63 | MP0002085_abnormal_embryonic_tissue | 1.16622576 |
| 64 | MP0003385_abnormal_body_wall | 1.15380729 |
| 65 | MP0001529_abnormal_vocalization | 1.15320823 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.15241852 |
| 67 | MP0000747_muscle_weakness | 1.14839762 |
| 68 | MP0005620_abnormal_muscle_contractility | 1.14360088 |
| 69 | MP0009672_abnormal_birth_weight | 1.14277306 |
| 70 | MP0005623_abnormal_meninges_morphology | 1.12740776 |
| 71 | MP0005187_abnormal_penis_morphology | 1.12066531 |
| 72 | MP0004147_increased_porphyrin_level | 1.11510708 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 1.11458265 |
| 74 | MP0005385_cardiovascular_system_phenoty | 1.09679240 |
| 75 | MP0001544_abnormal_cardiovascular_syste | 1.09679240 |
| 76 | MP0005670_abnormal_white_adipose | 1.09668785 |
| 77 | MP0000358_abnormal_cell_content/ | 1.09416367 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 1.09255009 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.07390391 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 1.06132388 |
| 81 | MP0005266_abnormal_metabolism | 1.05869968 |
| 82 | MP0008007_abnormal_cellular_replicative | 1.03991974 |
| 83 | MP0000750_abnormal_muscle_regeneration | 1.03901723 |
| 84 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03207633 |
| 85 | MP0003937_abnormal_limbs/digits/tail_de | 1.02561197 |
| 86 | MP0008877_abnormal_DNA_methylation | 0.99972329 |
| 87 | MP0002088_abnormal_embryonic_growth/wei | 0.99875120 |
| 88 | MP0000749_muscle_degeneration | 0.99549156 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99371368 |
| 90 | MP0002971_abnormal_brown_adipose | 0.99203026 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.99086042 |
| 92 | MP0001730_embryonic_growth_arrest | 0.98427540 |
| 93 | MP0003984_embryonic_growth_retardation | 0.98278676 |
| 94 | MP0002106_abnormal_muscle_physiology | 0.97026054 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.96718162 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.93873819 |
| 97 | MP0005380_embryogenesis_phenotype | 0.93597440 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 0.93597440 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.92954770 |
| 100 | MP0000462_abnormal_digestive_system | 0.92497881 |
| 101 | MP0005451_abnormal_body_composition | 0.92264526 |
| 102 | MP0003121_genomic_imprinting | 0.92031569 |
| 103 | MP0003718_maternal_effect | 0.91450147 |
| 104 | MP0002697_abnormal_eye_size | 0.91337650 |
| 105 | MP0009053_abnormal_anal_canal | 0.90852149 |
| 106 | MP0001756_abnormal_urination | 0.89966719 |
| 107 | MP0002127_abnormal_cardiovascular_syste | 0.89811594 |
| 108 | MP0003890_abnormal_embryonic-extraembry | 0.88633856 |
| 109 | MP0004145_abnormal_muscle_electrophysio | 0.88217888 |
| 110 | MP0010352_gastrointestinal_tract_polyps | 0.87629770 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.87107058 |
| 112 | MP0000537_abnormal_urethra_morphology | 0.85891040 |
| 113 | MP0003122_maternal_imprinting | 0.85714837 |
| 114 | MP0005171_absent_coat_pigmentation | 0.85105692 |
| 115 | MP0002234_abnormal_pharynx_morphology | 0.84206576 |
| 116 | MP0000598_abnormal_liver_morphology | 0.83675822 |
| 117 | MP0005367_renal/urinary_system_phenotyp | 0.83398101 |
| 118 | MP0000516_abnormal_urinary_system | 0.83398101 |
| 119 | MP0004197_abnormal_fetal_growth/weight/ | 0.83184548 |
| 120 | MP0004085_abnormal_heartbeat | 0.82982369 |
| 121 | MP0003786_premature_aging | 0.82355280 |
| 122 | MP0010307_abnormal_tumor_latency | 0.81740334 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.81176800 |
| 124 | MP0000759_abnormal_skeletal_muscle | 0.80966568 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.79553147 |
| 126 | MP0002084_abnormal_developmental_patter | 0.79224171 |
| 127 | MP0002086_abnormal_extraembryonic_tissu | 0.79162625 |
| 128 | MP0002090_abnormal_vision | 0.79122976 |
| 129 | MP0004957_abnormal_blastocyst_morpholog | 0.78246219 |
| 130 | MP0001764_abnormal_homeostasis | 0.78161473 |
| 131 | MP0002177_abnormal_outer_ear | 0.77289237 |
| 132 | MP0009703_decreased_birth_body | 0.76718950 |
| 133 | MP0005369_muscle_phenotype | 0.76513879 |
| 134 | MP0001697_abnormal_embryo_size | 0.76467924 |
| 135 | MP0006072_abnormal_retinal_apoptosis | 0.76217572 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.75815837 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.74733954 |
| 138 | MP0004484_altered_response_of | 0.74325443 |
| 139 | MP0002233_abnormal_nose_morphology | 0.73117940 |
| 140 | MP0005384_cellular_phenotype | 0.71415075 |
| 141 | MP0000428_abnormal_craniofacial_morphol | 0.71023249 |
| 142 | MP0005501_abnormal_skin_physiology | 0.70839690 |
| 143 | MP0000372_irregular_coat_pigmentation | 0.69939216 |
| 144 | MP0003119_abnormal_digestive_system | 0.69927990 |
| 145 | MP0001944_abnormal_pancreas_morphology | 0.69538597 |
| 146 | MP0002653_abnormal_ependyma_morphology | 0.68674524 |
| 147 | MP0000266_abnormal_heart_morphology | 0.67972700 |
| 148 | MP0001188_hyperpigmentation | 0.67315109 |
| 149 | MP0005334_abnormal_fat_pad | 0.67277589 |
| 150 | MP0000003_abnormal_adipose_tissue | 0.66336996 |
| 151 | MP0001346_abnormal_lacrimal_gland | 0.65526172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 5.92141372 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 5.77646336 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.66416703 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.55639578 |
| 5 | Ketoacidosis (HP:0001993) | 4.22671567 |
| 6 | Hyperglycinuria (HP:0003108) | 4.14358943 |
| 7 | Ketosis (HP:0001946) | 4.10916948 |
| 8 | Hyperglycinemia (HP:0002154) | 4.05864363 |
| 9 | Gout (HP:0001997) | 3.94093414 |
| 10 | Hyperammonemia (HP:0001987) | 3.92559155 |
| 11 | Myoglobinuria (HP:0002913) | 3.83700113 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.81042974 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 3.73936123 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.73936123 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 3.73224645 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.66278063 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 3.53404560 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.50926194 |
| 19 | Distal arthrogryposis (HP:0005684) | 3.49176043 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.46274403 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.37154527 |
| 22 | Xanthomatosis (HP:0000991) | 3.21786307 |
| 23 | Subaortic stenosis (HP:0001682) | 3.19361022 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.19361022 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.14150332 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.13812622 |
| 27 | Rimmed vacuoles (HP:0003805) | 3.13429014 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.09419986 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.05294713 |
| 30 | Hypoglycemic seizures (HP:0002173) | 3.04126637 |
| 31 | Hypolipoproteinemia (HP:0010981) | 3.00192021 |
| 32 | Hyperglycemia (HP:0003074) | 2.96158808 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.96080048 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 2.92646974 |
| 35 | Progressive muscle weakness (HP:0003323) | 2.85424501 |
| 36 | Calcaneovalgus deformity (HP:0001848) | 2.82902493 |
| 37 | Abnormality of the lower motor neuron (HP:0002366) | 2.82665373 |
| 38 | Sudden death (HP:0001699) | 2.79917982 |
| 39 | Increased purine levels (HP:0004368) | 2.78835204 |
| 40 | Hyperuricemia (HP:0002149) | 2.78835204 |
| 41 | Exercise-induced myalgia (HP:0003738) | 2.75345467 |
| 42 | EMG: myopathic abnormalities (HP:0003458) | 2.73174555 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.72450327 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 2.68348360 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.68348360 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.67639148 |
| 47 | Shoulder girdle muscle weakness (HP:0003547) | 2.66266669 |
| 48 | Abnormality of the calf musculature (HP:0001430) | 2.56484987 |
| 49 | Epidermoid cyst (HP:0200040) | 2.54101343 |
| 50 | Spastic diplegia (HP:0001264) | 2.52751897 |
| 51 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.52374812 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.50273633 |
| 53 | Deformed tarsal bones (HP:0008119) | 2.49794886 |
| 54 | Complement deficiency (HP:0004431) | 2.49416526 |
| 55 | Limb-girdle muscle atrophy (HP:0003797) | 2.47369931 |
| 56 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.46392314 |
| 57 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.46392314 |
| 58 | Skin nodule (HP:0200036) | 2.45268322 |
| 59 | Metabolic acidosis (HP:0001942) | 2.45061631 |
| 60 | Abnormality of alanine metabolism (HP:0010916) | 2.42376188 |
| 61 | Hyperalaninemia (HP:0003348) | 2.42376188 |
| 62 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.42376188 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42371332 |
| 64 | Myopathic facies (HP:0002058) | 2.42136199 |
| 65 | Hyperlipoproteinemia (HP:0010980) | 2.38925046 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.38855662 |
| 67 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.37768341 |
| 68 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.36198439 |
| 69 | Late onset (HP:0003584) | 2.35223374 |
| 70 | Palpitations (HP:0001962) | 2.35083858 |
| 71 | Lethargy (HP:0001254) | 2.34386004 |
| 72 | Cerebral edema (HP:0002181) | 2.33683031 |
| 73 | Lymphangioma (HP:0100764) | 2.33093627 |
| 74 | Hamartoma of the eye (HP:0010568) | 2.30109762 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.28066727 |
| 76 | Pelvic girdle muscle weakness (HP:0003749) | 2.27675928 |
| 77 | Neck muscle weakness (HP:0000467) | 2.26079553 |
| 78 | Microvesicular hepatic steatosis (HP:0001414) | 2.25981176 |
| 79 | Atrioventricular block (HP:0001678) | 2.25427468 |
| 80 | Hepatocellular carcinoma (HP:0001402) | 2.20714597 |
| 81 | Delayed CNS myelination (HP:0002188) | 2.17121692 |
| 82 | Proximal tubulopathy (HP:0000114) | 2.16589818 |
| 83 | Round ear (HP:0100830) | 2.16440394 |
| 84 | Areflexia of lower limbs (HP:0002522) | 2.16407273 |
| 85 | Bundle branch block (HP:0011710) | 2.16129810 |
| 86 | Microglossia (HP:0000171) | 2.15700020 |
| 87 | Absent phalangeal crease (HP:0006109) | 2.13515065 |
| 88 | Generalized aminoaciduria (HP:0002909) | 2.12650171 |
| 89 | Ependymoma (HP:0002888) | 2.12358680 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 2.10942362 |
| 91 | Muscle stiffness (HP:0003552) | 2.08540853 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 2.07459286 |
| 93 | Adenoma sebaceum (HP:0009720) | 2.06742240 |
| 94 | Angiofibromas (HP:0010615) | 2.06742240 |
| 95 | Ragged-red muscle fibers (HP:0003200) | 2.06701780 |
| 96 | Popliteal pterygium (HP:0009756) | 2.06658453 |
| 97 | Ventricular tachycardia (HP:0004756) | 2.04629551 |
| 98 | Progressive external ophthalmoplegia (HP:0000590) | 2.04305396 |
| 99 | Abnormality of methionine metabolism (HP:0010901) | 2.03204293 |
| 100 | Abnormality of the common coagulation pathway (HP:0010990) | 2.02573367 |
| 101 | Papillary thyroid carcinoma (HP:0002895) | 2.01601278 |
| 102 | Hypochromic microcytic anemia (HP:0004840) | 1.99582904 |
| 103 | Conjunctival hamartoma (HP:0100780) | 1.98739066 |
| 104 | Muscle fiber splitting (HP:0003555) | 1.98160556 |
| 105 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.98159821 |
| 106 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.95025469 |
| 107 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.95025469 |
| 108 | Calf muscle hypertrophy (HP:0008981) | 1.92444279 |
| 109 | Cholelithiasis (HP:0001081) | 1.92259792 |
| 110 | Pheochromocytoma (HP:0002666) | 1.92174669 |
| 111 | Abnormal finger flexion creases (HP:0006143) | 1.91981716 |
| 112 | Neoplasm of the adrenal gland (HP:0100631) | 1.91606766 |
| 113 | Back pain (HP:0003418) | 1.89475494 |
| 114 | Hyporeflexia of lower limbs (HP:0002600) | 1.89354790 |
| 115 | Increased connective tissue (HP:0009025) | 1.87049481 |
| 116 | Breech presentation (HP:0001623) | 1.86890274 |
| 117 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86519405 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 1.86005617 |
| 119 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85691929 |
| 120 | Neonatal onset (HP:0003623) | 1.85643616 |
| 121 | Symptomatic seizures (HP:0011145) | 1.85074330 |
| 122 | Oligomenorrhea (HP:0000876) | 1.84623847 |
| 123 | Limb-girdle muscle weakness (HP:0003325) | 1.83489752 |
| 124 | Asymmetric septal hypertrophy (HP:0001670) | 1.83218390 |
| 125 | Abnormality of the calcaneus (HP:0008364) | 1.82224436 |
| 126 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.82213342 |
| 127 | Heart block (HP:0012722) | 1.81463222 |
| 128 | Abnormal gallbladder morphology (HP:0012437) | 1.81148911 |
| 129 | Fat malabsorption (HP:0002630) | 1.80383508 |
| 130 | Multiple enchondromatosis (HP:0005701) | 1.80324331 |
| 131 | Abnormality of glycolysis (HP:0004366) | 1.78896709 |
| 132 | Increased serum pyruvate (HP:0003542) | 1.78896709 |
| 133 | Biliary tract neoplasm (HP:0100574) | 1.78200105 |
| 134 | Vomiting (HP:0002013) | 1.78098798 |
| 135 | Difficulty running (HP:0009046) | 1.75776155 |
| 136 | Septate vagina (HP:0001153) | 1.75224235 |
| 137 | Rhabdomyosarcoma (HP:0002859) | 1.71427024 |
| 138 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.70579307 |
| 139 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69403164 |
| 140 | Neoplasm of the small intestine (HP:0100833) | 1.63689514 |
| 141 | Myotonia (HP:0002486) | 1.60623862 |
| 142 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.60463787 |
| 143 | Termporal pattern (HP:0011008) | 1.59621505 |
| 144 | Insidious onset (HP:0003587) | 1.59621505 |
| 145 | Thyroid carcinoma (HP:0002890) | 1.59209238 |
| 146 | Abnormality of placental membranes (HP:0011409) | 1.58919271 |
| 147 | Amniotic constriction ring (HP:0009775) | 1.58919271 |
| 148 | Neuroendocrine neoplasm (HP:0100634) | 1.57846536 |
| 149 | Postnatal microcephaly (HP:0005484) | 1.57482201 |
| 150 | Exercise intolerance (HP:0003546) | 1.57096801 |
| 151 | Unilateral renal agenesis (HP:0000122) | 1.56768985 |
| 152 | Neoplasm of the rectum (HP:0100743) | 1.55612487 |
| 153 | Pterygium (HP:0001059) | 1.55612065 |
| 154 | Long clavicles (HP:0000890) | 1.54244956 |
| 155 | Metatarsus adductus (HP:0001840) | 1.54084040 |
| 156 | Abnormality of the umbilical cord (HP:0010881) | 1.53353333 |
| 157 | Cortical dysplasia (HP:0002539) | 1.52800190 |
| 158 | Scapular winging (HP:0003691) | 1.51226790 |
| 159 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.50883503 |
| 160 | Prominent metopic ridge (HP:0005487) | 1.50857273 |
| 161 | Medulloblastoma (HP:0002885) | 1.49965416 |
| 162 | Abnormal biliary tract morphology (HP:0012440) | 1.49371307 |
| 163 | Proximal amyotrophy (HP:0007126) | 1.49329371 |
| 164 | Premature rupture of membranes (HP:0001788) | 1.47143713 |
| 165 | Cutaneous melanoma (HP:0012056) | 1.46854408 |
| 166 | Ulnar deviation of the wrist (HP:0003049) | 1.46751564 |
| 167 | Dilated cardiomyopathy (HP:0001644) | 1.46321640 |
| 168 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.45803959 |
| 169 | Frequent falls (HP:0002359) | 1.44545389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.71333248 |
| 2 | BCKDK | 3.64407436 |
| 3 | PDK4 | 3.60129550 |
| 4 | PDK3 | 3.60129550 |
| 5 | NEK1 | 3.58560335 |
| 6 | PKN2 | 3.55288704 |
| 7 | SRPK1 | 2.97693989 |
| 8 | PBK | 2.77708301 |
| 9 | LATS1 | 2.42578324 |
| 10 | ERBB3 | 2.40762747 |
| 11 | MST4 | 2.40480805 |
| 12 | EIF2AK3 | 2.35758379 |
| 13 | BUB1 | 2.23502506 |
| 14 | TRIM28 | 2.13018111 |
| 15 | EIF2AK1 | 2.08303972 |
| 16 | LATS2 | 1.97811873 |
| 17 | STK38L | 1.93158116 |
| 18 | MAP2K4 | 1.93031562 |
| 19 | TAOK2 | 1.87865483 |
| 20 | TTN | 1.84091761 |
| 21 | PDK2 | 1.78583908 |
| 22 | FLT3 | 1.71560829 |
| 23 | CDK12 | 1.66137267 |
| 24 | MAP3K4 | 1.62239948 |
| 25 | MKNK1 | 1.61758683 |
| 26 | MAP3K5 | 1.61625335 |
| 27 | BCR | 1.57734151 |
| 28 | OBSCN | 1.49552730 |
| 29 | SCYL2 | 1.42291798 |
| 30 | MKNK2 | 1.36157959 |
| 31 | FRK | 1.33651696 |
| 32 | WNK3 | 1.33174672 |
| 33 | PRKD3 | 1.27877531 |
| 34 | LIMK1 | 1.27280861 |
| 35 | PDGFRA | 1.24180436 |
| 36 | TAF1 | 1.22396113 |
| 37 | INSRR | 1.22184960 |
| 38 | KSR1 | 1.20604120 |
| 39 | SIK1 | 1.19565641 |
| 40 | MAP3K12 | 1.19482968 |
| 41 | NEK2 | 1.19408235 |
| 42 | RPS6KA4 | 1.19221893 |
| 43 | NEK9 | 1.18938292 |
| 44 | AKT3 | 1.18296232 |
| 45 | STK38 | 1.11441965 |
| 46 | CDC7 | 1.11026547 |
| 47 | BRD4 | 1.09716910 |
| 48 | LMTK2 | 1.07847573 |
| 49 | CSNK1G1 | 1.06100263 |
| 50 | PHKG2 | 1.04254192 |
| 51 | PHKG1 | 1.04254192 |
| 52 | KSR2 | 1.02459824 |
| 53 | WEE1 | 1.00210823 |
| 54 | PTK6 | 0.99971905 |
| 55 | PINK1 | 0.98645173 |
| 56 | CCNB1 | 0.98471075 |
| 57 | PRKAA1 | 0.97206568 |
| 58 | WNK4 | 0.94398512 |
| 59 | PASK | 0.92965209 |
| 60 | CAMK1D | 0.92034701 |
| 61 | TTK | 0.89838028 |
| 62 | CSNK1G3 | 0.89793049 |
| 63 | RPS6KB2 | 0.89649100 |
| 64 | MAP3K6 | 0.86481373 |
| 65 | RIPK1 | 0.84931247 |
| 66 | STK24 | 0.84885835 |
| 67 | PAK6 | 0.84378519 |
| 68 | STK3 | 0.83892316 |
| 69 | PAK3 | 0.82585273 |
| 70 | ERN1 | 0.82516910 |
| 71 | RET | 0.82244586 |
| 72 | PNCK | 0.81978677 |
| 73 | MAP3K10 | 0.81926123 |
| 74 | CSNK1G2 | 0.80710799 |
| 75 | BRSK2 | 0.80555081 |
| 76 | AURKB | 0.79646199 |
| 77 | MOS | 0.77426677 |
| 78 | VRK2 | 0.77009522 |
| 79 | SGK3 | 0.76347968 |
| 80 | MAP2K7 | 0.75198310 |
| 81 | MAP2K6 | 0.75009728 |
| 82 | MTOR | 0.74919665 |
| 83 | FER | 0.74544518 |
| 84 | CSNK1A1L | 0.74520128 |
| 85 | ERBB4 | 0.74092322 |
| 86 | CDK6 | 0.69515806 |
| 87 | SGK2 | 0.69169048 |
| 88 | MAPK11 | 0.69140664 |
| 89 | CHEK1 | 0.68988088 |
| 90 | DMPK | 0.68692423 |
| 91 | CDK4 | 0.67157747 |
| 92 | MST1R | 0.66873253 |
| 93 | ACVR1B | 0.66126320 |
| 94 | MAP3K7 | 0.64403215 |
| 95 | ATR | 0.64215267 |
| 96 | ARAF | 0.63830033 |
| 97 | TYRO3 | 0.63209644 |
| 98 | FGFR4 | 0.62341992 |
| 99 | STK16 | 0.62234180 |
| 100 | ATM | 0.61881569 |
| 101 | CDK19 | 0.61322883 |
| 102 | EIF2AK2 | 0.61322573 |
| 103 | PLK4 | 0.61209181 |
| 104 | CDK7 | 0.60698271 |
| 105 | CHEK2 | 0.60325623 |
| 106 | VRK1 | 0.59999543 |
| 107 | WNK1 | 0.59387848 |
| 108 | AKT2 | 0.57924727 |
| 109 | PLK2 | 0.57744017 |
| 110 | MET | 0.57654975 |
| 111 | CAMK2D | 0.57474563 |
| 112 | FGFR1 | 0.57017356 |
| 113 | CAMKK1 | 0.56968290 |
| 114 | ALK | 0.56371378 |
| 115 | CDK14 | 0.55348367 |
| 116 | CDK18 | 0.54120304 |
| 117 | STK39 | 0.53363831 |
| 118 | MAP2K3 | 0.53266524 |
| 119 | PIM2 | 0.52477254 |
| 120 | PAK2 | 0.51945016 |
| 121 | TSSK6 | 0.51324718 |
| 122 | RPS6KB1 | 0.51307314 |
| 123 | PDPK1 | 0.50742042 |
| 124 | PLK3 | 0.49560986 |
| 125 | AURKA | 0.49350262 |
| 126 | MAP2K1 | 0.49045290 |
| 127 | MAP3K9 | 0.48933421 |
| 128 | TESK1 | 0.48503313 |
| 129 | ZAK | 0.48075049 |
| 130 | STK4 | 0.47468482 |
| 131 | PRKAA2 | 0.45581610 |
| 132 | CDK15 | 0.44951910 |
| 133 | ICK | 0.44314454 |
| 134 | DAPK2 | 0.43870284 |
| 135 | DAPK1 | 0.43533608 |
| 136 | CSNK1E | 0.43480868 |
| 137 | MAP3K8 | 0.43049745 |
| 138 | PDK1 | 0.42933083 |
| 139 | MINK1 | 0.42579023 |
| 140 | CDK11A | 0.42571788 |
| 141 | BRSK1 | 0.42336511 |
| 142 | PIK3CG | 0.41485513 |
| 143 | ILK | 0.41185257 |
| 144 | CAMK1G | 0.40599147 |
| 145 | CAMK2G | 0.40319622 |
| 146 | PLK1 | 0.39907407 |
| 147 | PTK2 | 0.39891569 |
| 148 | TRPM7 | 0.39308011 |
| 149 | NME2 | 0.38549766 |
| 150 | * CDK1 | 0.37905411 |
| 151 | SGK223 | 0.37322275 |
| 152 | SGK494 | 0.37322275 |
| 153 | MAP3K2 | 0.37289313 |
| 154 | EEF2K | 0.37032200 |
| 155 | MAP3K11 | 0.36244200 |
| 156 | PRKACG | 0.36220484 |
| 157 | PAK4 | 0.36181648 |
| 158 | MAPKAPK3 | 0.35667457 |
| 159 | DYRK1B | 0.33902229 |
| 160 | TAOK1 | 0.33720667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.00586083 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.93142712 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.57522324 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.12531003 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05609793 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97130216 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.84382349 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74228398 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69620633 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.55307901 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30230874 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.26553049 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.26368747 |
| 14 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.22744996 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.19021605 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.17572818 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.17427498 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12620464 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.97572683 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.96444348 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.95612958 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.93636973 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84517641 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.84108195 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.78117630 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73923484 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.68159551 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65439733 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.65354725 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62675580 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.62335875 |
| 32 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.56295818 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.56291320 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.49033749 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.45634860 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45119742 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.41687938 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41450739 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35309002 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29271640 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29224217 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27011408 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25478076 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.24891443 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23834427 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.23371833 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.22433765 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21050468 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18784253 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17543241 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12750697 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.11825660 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09514844 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06812042 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 1.00633025 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00070555 |
| 57 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95886322 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94844752 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91135713 |
| 60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.89889982 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.89498844 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89069166 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88678962 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.88400576 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.88346604 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.87214390 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87093580 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84623320 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84487588 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79943227 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79592328 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76344467 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74754800 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73203512 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72946716 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71388824 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70979430 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.70047239 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69947934 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69560656 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67581802 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66482725 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65603091 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65277615 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61280667 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60919093 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60627890 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59655199 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58262881 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58203094 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54873063 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54287907 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54100668 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52567476 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52459229 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51738025 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50895297 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49599712 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49135308 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.47215421 |
| 101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46773094 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46360347 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43603637 |
| 104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42663346 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.42302058 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41921260 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41485445 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39172884 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38338896 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35514483 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35116321 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.34284352 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33762391 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33662184 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32508901 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31737076 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29516249 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27612411 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27547113 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27283880 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26164161 |
| 122 | RNA transport_Homo sapiens_hsa03013 | 0.25550429 |
| 123 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24856737 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23742069 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.23460318 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21557908 |
| 127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18999437 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18984765 |
| 129 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.18948281 |
| 130 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.18419709 |
| 131 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.18078600 |
| 132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.17736449 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | 0.17421412 |
| 134 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17410754 |
| 135 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.15317432 |
| 136 | Parkinsons disease_Homo sapiens_hsa05012 | 0.14354478 |
| 137 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12976803 |
| 138 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12198721 |
| 139 | Bladder cancer_Homo sapiens_hsa05219 | 0.12122544 |
| 140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11594747 |

